262 related articles for article (PubMed ID: 26367086)
21. Optic neuritis.
Toosy AT; Mason DF; Miller DH
Lancet Neurol; 2014 Jan; 13(1):83-99. PubMed ID: 24331795
[TBL] [Abstract][Full Text] [Related]
22. Management of optic neuritis and multiple sclerosis.
Van Stavern GP
Curr Opin Ophthalmol; 2001 Dec; 12(6):400-7. PubMed ID: 11734679
[TBL] [Abstract][Full Text] [Related]
23. Optic neuritis in children.
Morales DS; Siatkowski RM; Howard CW; Warman R
J Pediatr Ophthalmol Strabismus; 2000; 37(5):254-9. PubMed ID: 11020105
[TBL] [Abstract][Full Text] [Related]
24. Optic neuritis.
Purvin V
Curr Opin Ophthalmol; 1998 Dec; 9(6):3-9. PubMed ID: 10387333
[TBL] [Abstract][Full Text] [Related]
25. Bilateral vision loss responsive to corticosteroids.
Lee MD; Song BJ; Odel JG; Sadun AA
Surv Ophthalmol; 2013; 58(6):634-9. PubMed ID: 23153758
[TBL] [Abstract][Full Text] [Related]
26. The natural history of optic neuritis.
Atkins EJ; Biousse V; Newman NJ
Rev Neurol Dis; 2006; 3(2):45-56. PubMed ID: 16819420
[TBL] [Abstract][Full Text] [Related]
27. Long-term brain magnetic resonance imaging changes after optic neuritis in patients without clinically definite multiple sclerosis.
Optic Neuritis Study Group
Arch Neurol; 2004 Oct; 61(10):1538-41. PubMed ID: 15477507
[TBL] [Abstract][Full Text] [Related]
28. Permeability of the blood-brain barrier predicts conversion from optic neuritis to multiple sclerosis.
Cramer SP; Modvig S; Simonsen HJ; Frederiksen JL; Larsson HB
Brain; 2015 Sep; 138(Pt 9):2571-83. PubMed ID: 26187333
[TBL] [Abstract][Full Text] [Related]
29. Development of a Prognostic Model for Predicting Multiple Sclerosis After Optic Neuritis: A Secondary Analysis of Data From the Optic Neuritis Treatment Trial.
Luo W; Deng X; Xu X; Song R; Luo M; Moss HE; Du Y
J Neuroophthalmol; 2022 Mar; 42(1):88-96. PubMed ID: 34860745
[TBL] [Abstract][Full Text] [Related]
30. Predictors of Long-Term Visual Acuity in a Modern Cohort of Patients With Acute Idiopathic and Multiple Sclerosis-Associated Optic Neuritis.
Jarocki A; Benard-Seguin E; Gonzalez LA; Costello F; Andrews CA; Kerber K; De Lott LB
J Neuroophthalmol; 2023 Dec; 43(4):475-480. PubMed ID: 37200095
[TBL] [Abstract][Full Text] [Related]
31. The dyschromatopsia of optic neuritis: a descriptive analysis of data from the optic neuritis treatment trial.
Katz B
Trans Am Ophthalmol Soc; 1995; 93():685-708. PubMed ID: 8719696
[TBL] [Abstract][Full Text] [Related]
32. Clinical features and outcome of childhood optic neuritis at Queen Sirikit National Institute of Child Health.
Sri-udomkajorn S; Pongwatcharaporn K
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S189-94. PubMed ID: 22043775
[TBL] [Abstract][Full Text] [Related]
33. Acute inflammatory demyelinating optic neuritis: current concepts in diagnosis and management.
Bhatti MT; Schmitt NJ; Beatty RL
Optometry; 2005 Sep; 76(9):526-35. PubMed ID: 16198993
[TBL] [Abstract][Full Text] [Related]
34. [A risk of developing multiple sclerosis following an outbreak of optic neuritis during a mean follow-up of 4.5 years].
Deyá E; Sevilla T; Coret F
Neurologia; 1998 Oct; 13(8):377-81. PubMed ID: 9859669
[TBL] [Abstract][Full Text] [Related]
35. [Optic neuritis--diagnosis, treatment and follow up].
Midgard R; Seland JH; Hovdal H; Celius EG; Eriksen K; Jensen D; Heger H; Mellgren SI; Wexler A; Beiske AG; Myhr KM
Tidsskr Nor Laegeforen; 2005 Feb; 125(4):425-8. PubMed ID: 15742012
[TBL] [Abstract][Full Text] [Related]
36. Isolated bilateral optic neuritis in acute disseminated encephalomyelitis.
Bangsgaard R; Larsen VA; Milea D
Acta Ophthalmol Scand; 2006 Dec; 84(6):815-7. PubMed ID: 17083545
[TBL] [Abstract][Full Text] [Related]
37. Erythropoietin for acute multiple sclerosis in patients with optic neuritis as a first demyelination event.
Borhani-Haghighi A; Ghodsi M; Razeghinejad MR; Mardani S; Mardani M; Nikseresht AR; Safari A; Bagheri MH
Neurosciences (Riyadh); 2012 Apr; 17(2):151-5. PubMed ID: 22465890
[TBL] [Abstract][Full Text] [Related]
38. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.
Beck RW; Cleary PA; Anderson MM; Keltner JL; Shults WT; Kaufman DI; Buckley EG; Corbett JJ; Kupersmith MJ; Miller NR
N Engl J Med; 1992 Feb; 326(9):581-8. PubMed ID: 1734247
[TBL] [Abstract][Full Text] [Related]
39. The impact of the optic neuritis treatment trial on the practices of ophthalmologists and neurologists.
Trobe JD; Sieving PC; Guire KE; Fendrick AM
Ophthalmology; 1999 Nov; 106(11):2047-53. PubMed ID: 10571336
[TBL] [Abstract][Full Text] [Related]
40. Clinical characteristics of optic neuritis in Hong Kong population: 10-year review.
Choy BNK; Ng ALK; Lai JSM
Int Ophthalmol; 2018 Apr; 38(2):557-564. PubMed ID: 28289949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
